NUESTRA ENHORABUENA A ASPRONA POR SU 50 ANIVERSARIO.
La Asociación Protectora de Personas con Discapacidad Intelectual celebra hoy su medio siglo de vida. Con el reto de “abordar el futuro de la discapacidad intelectual en una situación complicada” llevan ya 50 años en marcha y, desde Fundación Emilio Moro, queremos transmitir nuestro apoyo a todo el equipo y desearles que sigan activos muchos años más. Como ha dicho hoy su Presidente, Manuel Fernández, "al menos, otros 50 años".
Aprovechamos la oportunidad para transmitir también nuestro apoyo a las empresas que invierten en Responsabilidad Social Empresarial (RSE) pero sin limitarse al plano económico. La RSE implica COMPROMISO.
Tanto BODEGAS EMILIO MORO como CEPA 21, consideran fundamental este aspecto dentro de su filosofía. Parte de los beneficios que reciben son reinvertidos en la compañía, en el área local y en la comunidad internacional. De hecho, tienen varios acuerdos firmados con diferentes organizaciones para impulsar la Política de RSE de la empresa, como:
EL PACTO MUNDIAL DE LAS NACIONES UNIDAS, que trata 10 principios básicos de conducta y acción en materia de Derechos Humanos, trabajo, medio ambiente y lucha contra la corrupción en las operaciones diarias de la empresa.
PROGRAMA WINE IN MODERATION, por un consumo responsable del vino.
CONVENIO DE COLABORACIÓN CON LA ONCE, con el fin de favorecer la inserción laboral de las personas afiliadas y la accesibilidad de las visitas a las instalaciones de la Bodega, realizando técnicas descriptivas necesarias para adaptar el medio a personas invidentes o con deficiencias visuales y, en definitiva, potenciar un acercamiento entre ambas entidades.
Por todo ello, nos identificamos plenamente con la labor desarrollada durante estos 50 años por ASPRONA y les animamos a continuar en su labor integradora.
Check out Chapters 1 & 2 of our Overview of the Medical Landscape course to get a sample of the quality of information and instruction offered by <a>Cardiac & Technical Sales Training Institute</a>.
NUESTRA ENHORABUENA A ASPRONA POR SU 50 ANIVERSARIO.
La Asociación Protectora de Personas con Discapacidad Intelectual celebra hoy su medio siglo de vida. Con el reto de “abordar el futuro de la discapacidad intelectual en una situación complicada” llevan ya 50 años en marcha y, desde Fundación Emilio Moro, queremos transmitir nuestro apoyo a todo el equipo y desearles que sigan activos muchos años más. Como ha dicho hoy su Presidente, Manuel Fernández, "al menos, otros 50 años".
Aprovechamos la oportunidad para transmitir también nuestro apoyo a las empresas que invierten en Responsabilidad Social Empresarial (RSE) pero sin limitarse al plano económico. La RSE implica COMPROMISO.
Tanto BODEGAS EMILIO MORO como CEPA 21, consideran fundamental este aspecto dentro de su filosofía. Parte de los beneficios que reciben son reinvertidos en la compañía, en el área local y en la comunidad internacional. De hecho, tienen varios acuerdos firmados con diferentes organizaciones para impulsar la Política de RSE de la empresa, como:
EL PACTO MUNDIAL DE LAS NACIONES UNIDAS, que trata 10 principios básicos de conducta y acción en materia de Derechos Humanos, trabajo, medio ambiente y lucha contra la corrupción en las operaciones diarias de la empresa.
PROGRAMA WINE IN MODERATION, por un consumo responsable del vino.
CONVENIO DE COLABORACIÓN CON LA ONCE, con el fin de favorecer la inserción laboral de las personas afiliadas y la accesibilidad de las visitas a las instalaciones de la Bodega, realizando técnicas descriptivas necesarias para adaptar el medio a personas invidentes o con deficiencias visuales y, en definitiva, potenciar un acercamiento entre ambas entidades.
Por todo ello, nos identificamos plenamente con la labor desarrollada durante estos 50 años por ASPRONA y les animamos a continuar en su labor integradora.
Check out Chapters 1 & 2 of our Overview of the Medical Landscape course to get a sample of the quality of information and instruction offered by <a>Cardiac & Technical Sales Training Institute</a>.
Brand Differentiation in the Pharmaceutical Industry: Interview with: Robert Finkel, Principal & Chief Creative Officer, Kane & Finkel Healthcare Communications, a sponsor company at the marcus evans PharmaBrand Summit 2012, on differentiating brands in the highly restricted pharmaceuticals industry.
Head-to-Head Comparative Study of Two Optical Biometric Devices in Modern Cat...SM2 Strategic
Today's cataract surgeon has adopted non-contact optical
biometry as the standard of care in performing IOL calculations.
While modern formulae incorporate multiple variables as part
of their calculations, Axial Length and Keratometry readings
continue to be the inputs that are most influential in determining
IOL power. Some of the newer generation formulas such as
Holladay 2 and Olsen now incorporate more elements to help
increase accuracy.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Evaluation of antidepressant activity of clitoris ternatea in animals
Dare to be different
1. TODAY’S PRACTICE
Marketing Mishaps
Dare to Be Different
Is all LASIK created equal?
BY SHAREEF MAHDAVI
T
here’s a problem with Virtually all great brands of
how LASIK is being product or service have carved
perceived by the pub- out a unique position that causes
lic. It’s gone from the consumer to value it and
being thought of as a miracle often pay more for it than a non-
to becoming a generic com- distinguished offering in the same
modity product. It seems like category. If people can perceive
providers have been “dumbing differences among basic house-
down” the benefits and risks of hold items—ice cream, laundry
the procedure to the point soap, and mustard, just to name a
where the public thinks LASIK few—then people can certainly
is the same procedure no mat- perceive differences among LASIK
ter who performs it. providers, especially given the
Just like the old saying, “no complex nature of the product
two people are alike,” no two and the decision process of
ophthalmologists are alike acquiring it.
either. The profession has large-
ly missed this point, either MAKE A SACRIFICE
because members haven’t con- In order to achieve a position,
sidered how each one of them well-known brands had to focus
is unique, or because they have failed to communicate their product or service offering, actively selecting one
what makes them special. If you think of LASIK as the point of difference and sacrificing others. Providers have
product, then the sum total of everything you do—not been reluctant to do this, mainly out of fear of limiting
just clinical results—becomes your product offering. And their appeal. As is the case with targeted marketing,
as long as the bulk of providers fails to distinguish how which narrows the scope of the audience, effective posi-
their product offering is different, LASIK will continue to tioning requires you to distinguish among all the things
be stigmatized as a generic solution to vision correction. you do and all the benefits you provide and narrow the
focus of what you communicate to the outside world.
WHAT’S THE DIFFERENCE? Attempts by LASIK providers to create positions have
What every provider should be aiming for is a unique varied in their uniqueness and their success. Using tech-
position in their market place. Positioning is a market- nology is expensive and will be matched by other
ing term defined as how you differentiate your offering in providers who have deep financial resources. Using low
the mind of your prospect. This marketing concept yields price is also expensive (think “lost profits”) and very easily
two related truths. matched. Focusing on a milestone attribute, such as
“first to perform” in the market, “most procedures in the
Truth No. 1 market,” or “treated a particular celebrity in the market”
You must effectively differentiate yourself and communicate are better but limited to a select few.
that difference in order to have sustaining success. Every provider needs to ask, “Why should patients
choose me to perform their LASIK?” The answer to this
Truth No. 2 question is the first step in developing a differentiated
Everything can be differentiated. service offering. It’s an important question to answer,
APRIL 2002 I CATARACT & REFRACTIVE SURGERY TODAY I 59
2. TODAY’S PRACTICE
because every person out there considering LASIK is ask- known for taking exceptional care of patients’ needs
ing themselves the mirror-image question: “Why should I prior to surgery, you will likely achieve the halo effect of
choose you to perform LASIK on me?” being perceived as a great surgeon. Conversely, if your
Even if you aren’t one of the surgeons who performed reception area is sloppy, you will likely be perceived as
the first LASIK procedure, don’t perform the most LASIK being a sloppy surgeon. It doesn’t matter what reality is,
procedures, or don’t offer the newest twist in LASIK, you people create perceptions which, once formed, are
need to determine your own point of distinction. You mighty hard to change.
will have to work hard to find the answer, but the alter- Walk into any business, such as a restaurant, and within
native is to be thought of as “no better or worse than the seconds you can pick up and perceive differences, each
next doctor”. That title is not motivating enough to have with a distinct genetic code that defines its level of service.
someone choose you.
Your answer needs to be unique to you and believable GO BEYOND RE SULTS
to prospective patients. Take inventory of what you cur- Because you are in a service business, it’s important to
rently do to attract refractive surgery candidates. Ask remember that service amounts to much more than the
prior patients what they LASIK procedure itself.
remembered and valued Patients are paying for the
about the procedure they “Every provider needs to ask, entire experience—before,
had with you and your ‘Why should patients choose me during, and after surgery.
staff. Analyze your patient It’s up to you to examine
database to see if a specific to perform their LASIK?’” every aspect of your service
patient niche or grouping to find out what you’re
emerges. In short, make doing extremely well (that
your point of differentiation one that reflects you, your might be different enough to become a distinction of
staff and your patients. It should be something you live your offering), as well as what needs to be improved. This
and breathe daily. includes the clinical results of the procedure, yet extends
well beyond.
M ARKETING TR APS TO AVOID If the profession stands a chance to increase the overall
There are some pitfalls to watch for when deciding demand for refractive surgery, then LASIK—today’s dom-
how to differentiate yourself. Following are a few of the inant procedure—must move away from being perceived
most common. as a generic offering from generic providers. New tech-
niques (e.g. custom ablation) and new procedures (e.g.
Trap No. 1 phakic IOLs) will always be on the horizon, but they are
Keep in mind that your positioning can’t be something not going to carry your unique and differentiated service
that everyone aspires to have and to which no one wants offering. They will become part of your product mix, and
the alternative. For example, “quality” and “trust” are weak they will be part of everyone else’s too. If you want to
distinctions; everyone strives to achieve them. restore the shine in the LASIK jewel today, then take a
hard look at how you communicate about the procedure
Trap No. 2 and your offering.
You need to stop thinking of marketing as advertising. Differentiation among providers offers greater per-
Marketing is the sum total of everything you do to ceived choice to the consumer, and will help build the
attract and retain patients. Whether you advertise or perception that “not all LASIK is created equal.”
not, your prospects for LASIK perceive differences right Next month, we’ll look at how differentiation plays into
away: how they’re greeted on the phone, how you competition and try to answer the question, “with whom
respond to their questions, and how they’re treated dur- are we truly competing for refractive surgery patients?” ■
ing an evaluation. Consider this: A LASIK evaluation
works both ways. Each month, industry veteran Shareef Mahdavi looks at
a different topic relating to the business of refractive surgery,
Trap No. 3 exploring how mistakes from the past can be used by all
Avoid trying to be “all things to all people.” In the providers for more effective marketing.
prospect’s mind, there are two forces at work. One is that He formerly was the head of marketing for VISX and is
there is a limit to how much a mind can perceive and based in Pleasanton, California. Mr. Mahdavi may be
retain. The other is that people associate. If you are reached at (925) 425-9963; shareef@sm2consulting.com
APRIL 2002 I CATARACT & REFRACTIVE SURGERY TODAY I 61